IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. 
Trial record 7 of 12 for:
glioblastoma nivolumab
An Investigational Immuno-therapy Study of Temozolomide Plus Radiation Therapy With Nivolumab or Placebo, for Newly Diagnosed Patients With Glioblastoma (GBM, a Malignant Brain Cancer) (CheckMate548)
This study is currently recruiting participants.
Verified July 2017 by Bristol-Myers Squibb
Sponsor:
Bristol-Myers Squibb
Collaborator:
Ono Pharmaceutical Co. Ltd
Information provided by (Responsible Party):
Bristol-Myers Squibb
ClinicalTrials.gov Identifier:
NCT02667587
First received: January 26, 2016
Last updated: July 19, 2017
Last verified: July 2017
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate patients with glioblastoma that is MGMT-methylated (the MGMT gene is altered by a chemical change). Patients will receive temozolomide plus radiation therapy. They will be compared to patients receiving Nivolumab in addition to temozolomide plus radiation therapy.
| Condition | Intervention | Phase |
|---|---|---|
| Brain Neoplasms | Drug: Nivolumab Drug: Temozolomide Radiation: Radiotherapy Other: Nivolumab Placebo | Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Parallel Assignment Masking: Triple (Participant, Care Provider, Investigator) Primary Purpose: Treatment |
| Official Title: | A Randomized Phase 3 Single Blind Study of Temozolomide Plus Radiation Therapy Combined With Nivolumab or Placebo in Newly Diagnosed Adult Subjects With MGMT-Methylated (Tumor O6-methylguanine DNA Methyltransferase) Glioblastoma |
Resource links provided by NLM:
Further study details as provided by Bristol-Myers Squibb:
Primary Outcome Measures:
- Overall survival (OS) defined as time from the date of randomization to the date of death. [ Time Frame: Approximately 69 months after first patient first visit ]
Secondary Outcome Measures:
- Progression free survival (PFS), defined as the time from randomization to the date of the first documented tumor progression or death to any cause. [ Time Frame: Approximately 69 months after first patient first visit ]
- Correlation of PFS and OS [ Time Frame: Approximately 69 months after first patient first visit ]
| Estimated Enrollment: | 693 |
| Actual Study Start Date: | May 5, 2016 |
| Estimated Study Completion Date: | January 8, 2023 |
| Estimated Primary Completion Date: | November 6, 2021 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Nivolumab + Temozolomide + Radiotherapy
Nivolumab: specified dose on specified days; IV (intravenous) infusion Temozolomide: 75 mg (milligram)/meter squared daily during Radiotherapy, 4 week treatment break, 150 mg/meter squared Day 1-5 for Cycle 1 and increased to 200 mg/meter squared Day 1-5 for Cycle2-Cycle 6 as tolerated; orally (additional cycles may be permitted with approval of sponsor) Radiotherapy: 2 gray units (joule of radiation energy per kilogram) 5 times per week for 6 weeks
|
Drug: Nivolumab
Other Names:
Drug: Temozolomide
Other Names:
Radiation: Radiotherapy
Other Name: RT
|
|
Placebo Comparator: Nivolumab placebo + Temozolomide + Radiotherapy
Nivolumab Placebo: specified dose on specified days; IV infusion Temozolomide: 75 mg/meter squared daily during Radiotherapy, 4 week treatment break, 150 mg/meter squared Day 1-5 for Cycle 1 and increased to 200 mg/meter squared Day 1-5 for Cycle2-Cycle 6 as tolerated; orally (additional cycles may be permitted with approval of sponsor) Radiotherapy: 2 gray units 5x/week x 6 weeks
|
Drug: Temozolomide
Other Names:
Radiation: Radiotherapy
Other Name: RT
Other: Nivolumab Placebo
|
Eligibility| Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | No |
Criteria
For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com
Inclusion Criteria:
- Males and Females, age ≥ 18 years old
- Newly diagnosed brain cancer or tumor called glioblastoma or GBM
- Karnofsky performance status of ≥ 70 (able to take care of self)
- Substantial recovery from surgery resection
- Tumor test result shows MGMT methylated or indeterminate tumor subtype
Exclusion Criteria:
- Biopsy-only of GBM with less than 20% of tumor removed
- Prior treatment for GBM (other than surgical resection)
- Any known tumor outside of the brain
- Recurrent or secondary GBM
- Active known or suspected autoimmune disease
Other protocol defined inclusion/exclusion criteria could apply
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT02667587
Hide Study Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT02667587
Contacts
| Contact: Recruiting sites have contact information. Please contact the sites directly. If there is no contact information, please email: | Clinical.Trials@bms.com | ||
| Contact: First line of the email MUST contain NCT# and Site #. |
Hide Study Locations
Locations
| United States, Alabama | |
| University of Alabama at Birmingham | Recruiting |
| Birmingham, Alabama, United States, 35294-3410 | |
| Contact: Louis Nabors, Site 0023 | |
| United States, Arizona | |
| St. Joseph Hospital And Medical Center | Recruiting |
| Phoenix, Arizona, United States, 85013 | |
| Contact: Lynn Ashby, Site 0003 | |
| United States, California | |
| Cedars Sinai Medical Center | Recruiting |
| Los Angeles, California, United States, 90048 | |
| Contact: Surasak Phuphanich, Site 0026 310-423-4513 | |
| UCLA Neuro-Oncology Program | Recruiting |
| Los Angeles, California, United States, 90095-1769 | |
| Contact: Timothy Cloughesy, Site 0010 310-794-3521 | |
| Sutter Institute For Medical Research | Recruiting |
| Sacramento, California, United States, 95816 | |
| Contact: Stacy Dandre, Site 0128 916-453-5800 | |
| Sharp Memorial Hospital | Recruiting |
| San Diego, California, United States, 92123 | |
| Contact: Charles Redfern, Site 0029 619-502-3241 | |
| The Regents of the University of California, San Francisco | Recruiting |
| San Francisco, California, United States, 94143-0372 | |
| Contact: Jennie Taylor, Site 0006 | |
| United States, Connecticut | |
| Yale University School Of Medicine | Recruiting |
| New Haven, Connecticut, United States, 06520 | |
| Contact: Joachim Baehring, Site 0004 | |
| United States, District of Columbia | |
| Georgetown University | Recruiting |
| Washington, D.C., District of Columbia, United States, 20007 | |
| Contact: Deepa Subramaniam, Site 0031 202-687-8962 | |
| United States, Florida | |
| University Of Miami Sylvester Comprehensive Cancer Center | Recruiting |
| Miami, Florida, United States, 33136 | |
| Contact: Macarena De La Fuente, Site 0087 305-243-3111 | |
| Moffitt Cancer Center | Recruiting |
| Tampa, Florida, United States, 33612 | |
| Contact: Solmaz Sahebjam, Site 0030 813-745-7991 | |
| United States, Illinois | |
| Local Institution | Not yet recruiting |
| Chicago, Illinois, United States, 60637 | |
| Contact: Site 0022 | |
| United States, Kansas | |
| University Of Kansas Medical Center | Recruiting |
| Westwood, Kansas, United States, 66205 | |
| Contact: Sarah Taylor, Site 0060 913-588-1886 | |
| United States, Kentucky | |
| Norton Cancer Institute | Recruiting |
| Louisville, Kentucky, United States, 40202 | |
| Contact: Renato La Rocca, Site 0018 | |
| United States, Maryland | |
| Johns Hopkins University School Of Medicine | Recruiting |
| Baltimore, Maryland, United States, 21287 | |
| Contact: Michael Lim, Site 0020 | |
| United States, Massachusetts | |
| Dana-Farber Cancer Institute | Recruiting |
| Boston, Massachusetts, United States, 02215 | |
| Contact: David Reardon, Site 0028 617-632-4876 | |
| Local Institution | Not yet recruiting |
| Boston, Massachusetts, United States, 02215 | |
| Contact: Site 0037 | |
| Massachusetts General Hospital | Recruiting |
| Boston, Massachusetts, United States, 02215 | |
| Contact: David Reardon, Site 0011 617-643-1933 | |
| United States, Michigan | |
| Henry Ford Health System | Recruiting |
| Detroit, Michigan, United States, 48202 | |
| Contact: Tobias Walbert, Site 0035 | |
| United States, Missouri | |
| Washington University School Of Medicine | Recruiting |
| Saint Louis, Missouri, United States, 63110 | |
| Contact: George Ansstas, Site 0002 314-286-0896 | |
| United States, New Jersey | |
| JFK Medical Center | Recruiting |
| Edison, New Jersey, United States, 08820-3947 | |
| Contact: Joseph Landolfi, Site 0017 732-321-7000 | |
| Hackensack University Medical Center | Recruiting |
| Hackensack, New Jersey, United States, 07601 | |
| Contact: Samuel Goldlust, Site 0012 551-996-5098 | |
| United States, New York | |
| Columbia University | Recruiting |
| New York, New York, United States, 10032 | |
| Contact: Fabio Iwamoto, Site 0015 | |
| Memorial Sloan Kettering Cancer Center | Recruiting |
| New York, New York, United States, 10065 | |
| Contact: Antonio Omuro, Site 0024 | |
| United States, North Carolina | |
| Levine Cancer Institute | Recruiting |
| Charlotte, North Carolina, United States, 28204 | |
| Contact: Ashley Sumrall, Site 0032 | |
| Preston Robert Tisch Brain Tumor Center at Duke University | Recruiting |
| Durham, North Carolina, United States, 27710 | |
| Contact: Katherine Peters, Site 0033 919-681-9932 | |
| United States, Ohio | |
| Cleveland Clinic | Recruiting |
| Cleveland, Ohio, United States, 44195 | |
| Contact: Manmeet Ahluwalia, Site 0001 216-445-3407 | |
| The Ohio State University Wexner Medical Center | Recruiting |
| Columbus, Ohio, United States, 43210 | |
| Contact: Raju Raval, Site 0027 614-685-2435 | |
| United States, Pennsylvania | |
| Lehigh Valley Health Network | Recruiting |
| Allentown, Pennsylvania, United States, 18103 | |
| Contact: Suresh Nair, Site 0098 610-402-0636 | |
| Thomas Jefferson University | Recruiting |
| Philadelphia, Pennsylvania, United States, 19107 | |
| Contact: Lyndon Kim, Site 0016 215-503-9110 | |
| United States, South Carolina | |
| Medical University Of South Carolina | Recruiting |
| Charleston, South Carolina, United States, 29425 | |
| Contact: Scott Lindhorst, Site 0021 843-792-9016 | |
| United States, Tennessee | |
| Erlanger Oncology & Hematology - Univ. of TN | Recruiting |
| Chattanooga, Tennessee, United States, 37403 | |
| Contact: Robert Graham, Site 0013 423-778-2982 | |
| Vanderbilt University Medical Center | Recruiting |
| Nashville, Tennessee, United States, 37232 | |
| Contact: Stephen Clark, Site 0008 615-936-8606 | |
| United States, Texas | |
| University Of Texas Southwestern Medical Center | Recruiting |
| Dallas, Texas, United States, 75390 | |
| Contact: Edward Pan, Site 0025 214-648-1929 | |
| Local Institution | Not yet recruiting |
| Houston, Texas, United States, 77030 | |
| Contact: Site 0036 | |
| United States, Utah | |
| Huntsman Cancer Institute | Recruiting |
| Salt Lake City, Utah, United States, 84112 | |
| Contact: Adam Cohen, Site 0009 801-587-4433 | |
| United States, Washington | |
| Swedish Neuroscience Institute | Recruiting |
| Seattle, Washington, United States, 98122 | |
| Contact: Tara Benkers, Site 0005 206-386-3878 | |
| Australia, New South Wales | |
| Local Institution | Recruiting |
| Liverpool, New South Wales, Australia, 2017 | |
| Contact: Site 0049 | |
| Royal North Shore Hospital | Recruiting |
| St. Leonards, New South Wales, Australia, 2065 | |
| Contact: Mustafa Khasraw, Site 0052 +61294631373 | |
| Australia, Victoria | |
| Local Institution | Recruiting |
| Heidelberg, Victoria, Australia, 3084 | |
| Contact: Site 0050 | |
| Local Institution | Recruiting |
| Prahran, Victoria, Australia, 3181 | |
| Contact: Site 0051 | |
| Australia, Western Australia | |
| Sir Charles Gairdner Hospital | Recruiting |
| Nedlands, Western Australia, Australia, 6009 | |
| Contact: Anna Nowak, Site 0122 +61408818656 | |
| Austria | |
| Kepler Universitaetsklinikum | Recruiting |
| Linz, Austria, 4020 | |
| Contact: Josef Pichler, Site 0062 | |
| Medical University Of Vienna | Recruiting |
| Vienna, Austria, 1090 | |
| Contact: Matthias Preusser, Site 0061 | |
| Belgium | |
| Universitair Ziekenhuis Brussel | Recruiting |
| Brussels, Belgium, 1090 | |
| Contact: Bart Neyns, Site 0070 +3224775457 | |
| Cliniques Universitaires Saint-Luc | Recruiting |
| Bruxelles, Belgium, 1200 | |
| Contact: Nicolas Whenham, Site 0069 +3210437147 | |
| Uz Leuven | Recruiting |
| Leuven, Belgium, 3000 | |
| Contact: Paul Clement, Site 0071 +3216346903 | |
| Canada, British Columbia | |
| British Columbia Cancer Agency-Vancouver Ctr | Recruiting |
| Vancouver, British Columbia, Canada, V5Z 4E6 | |
| Contact: Brian Thiessen, Site 0046 6048776000 | |
| Canada, Ontario | |
| Princess Margaret Cancer Centre | Recruiting |
| Toronto, Ontario, Canada, M5G 2M9 | |
| Contact: Warren Mason, Site 0048 4165817823 | |
| Canada, Quebec | |
| Montreal Neurological Institute and Hospital | Recruiting |
| Montreal, Quebec, Canada, H3A 2B4 | |
| Contact: Kevin Petrecca, Site 0047 5143982801 | |
| Denmark | |
| Local Institution | Recruiting |
| Copenhagen, Denmark, 2100 | |
| Contact: Site 0084 | |
| Local Institution | Recruiting |
| Odense C, Denmark, 5000 | |
| Contact: Site 0085 | |
| France | |
| Local Institution | Recruiting |
| Bobigny, France, 93009 | |
| Contact: Site 0038 | |
| Local Institution | Recruiting |
| Lille Cedex, France, 59037 | |
| Contact: Site 0043 | |
| Local Institution | Recruiting |
| Lyon Cedex 03, France, 69394 | |
| Contact: Site 0041 | |
| Local Institution | Recruiting |
| Marseille, France, 13385 | |
| Contact: Site 0040 | |
| Local Institution | Recruiting |
| Nancy, France, 54035 | |
| Contact: Site 0042 | |
| Local Institution | Recruiting |
| Paris cedex 13, France, 75651 | |
| Contact: Site 0039 | |
| Local Institution | Recruiting |
| Rennes Cedex, France, 35042 | |
| Contact: Site 0044 | |
| Local Institution | Recruiting |
| Toulouse, France, 31100 | |
| Contact: Site 0045 | |
| Germany | |
| Universitaetsklinikum Bonn | Recruiting |
| Bonn, Germany, 53105 | |
| Contact: Ulrich Herrlinger, Site 0055 +4922828719887 | |
| Uniklinik Erlangen | Recruiting |
| Erlangen, Germany, 91054 | |
| Contact: Martin Uhl, Site 0123 +4991318534640 | |
| Klinikum Der J. W. Goethe-Universitaet Frankfurt/Main | Recruiting |
| Frankfurt Am Main, Germany, 60528 | |
| Contact: Oliver Baehr, Site 0053 +4969630187711 | |
| Medizinische Universitaetsklinik Freiburg | Recruiting |
| Freiburg, Germany, 79106 | |
| Contact: Oliver Schnell, Site 0124 | |
| Universitaetsklinikum Hamburg | Recruiting |
| Hamburg, Germany, 20246 | |
| Contact: Manfred Westphal, Site 0057 +4940741035316 | |
| Universitaetsklinik Heidelberg | Recruiting |
| Heidelberg, Germany, 69120 | |
| Contact: Antje Wick, Site 0056 +4962215638265 | |
| Universitaetsklinik Koeln | Recruiting |
| Koeln, Germany, 50937 | |
| Contact: Norbert Galldiks, Site 0131 | |
| Universitaetsklinikum Muenster | Recruiting |
| Muenster, Germany, 48149 | |
| Contact: Oliver Grauer, Site 0054 +492518346814 | |
| Klinikum rechts der Isar der Technischen Universitat Munchen | Recruiting |
| Munich, Germany, 81675 | |
| Contact: Stephanie Combs, Site 0130 | |
| Local Institution | Recruiting |
| Regensburg, Germany, 93053 | |
| Contact: Site 0058 | |
| Universitasklinikum Tubingen | Recruiting |
| Tuebingen, Germany, 72076 | |
| Contact: Ghazaleh Tabatabai, Site 0059 +491729031130 | |
| Israel | |
| Local Institution | Recruiting |
| Petach Tikva, Israel, 49100 | |
| Contact: Site 0094 | |
| Local Institution | Recruiting |
| Tel Aviv, Israel, 64239 | |
| Contact: Site 0093 | |
| Italy | |
| Local Institution | Recruiting |
| Bologna, Italy, 40139 | |
| Contact: Site 0088 | |
| Local Institution | Recruiting |
| Milano, Italy, 20133 | |
| Contact: Site 0089 | |
| Local Institution | Recruiting |
| Padova, Italy, 35128 | |
| Contact: Site 0092 | |
| Local Institution | Recruiting |
| Rozzano (milano), Italy, 20089 | |
| Contact: Site 0127 | |
| Local Institution | Recruiting |
| Siena, Italy, 53100 | |
| Contact: Site 0090 | |
| Local Institution | Recruiting |
| Torino, Italy, 10126 | |
| Contact: Site 0091 | |
| Japan | |
| Local Institution | Recruiting |
| Nagoya-shi, Aichi, Japan, 4668560 | |
| Contact: Site 0110 | |
| Local Institution | Recruiting |
| Chiba-shi, Chiba, Japan, 2600856 | |
| Contact: Site 0099 | |
| Local Institution | Recruiting |
| Hiroshima-Shi, Hiroshima, Japan, 7348551 | |
| Contact: Site 0100 | |
| Local Institution | Recruiting |
| Sapporo-shi, Hokkaido, Japan, 0608648 | |
| Contact: Site 0101 | |
| Local Institution | Recruiting |
| Kobe-shi, Hyogo, Japan, 650-0017 | |
| Contact: Site 0105 | |
| Local Institution | Recruiting |
| Tsukuba-shi, Ibaraki, Japan, 3058576 | |
| Contact: Site 0116 | |
| Local Institution | Recruiting |
| Kanazawa-shi, Ishikawa, Japan, 9200934 | |
| Contact: Site 0103 | |
| Local Institution | Recruiting |
| Kagoshima-shi, Kagoshima, Japan, 8908520 | |
| Contact: Site 0102 | |
| Local Institution | Recruiting |
| Sagamihara-shi, Kanagawa, Japan, 2520375 | |
| Contact: Site 0118 | |
| Local Institution | Recruiting |
| Kumamoto-shi, Kumamoto, Japan, 8608556 | |
| Contact: Site 0106 | |
| Local Institution | Recruiting |
| Kyoto-shi, Kyoto, Japan, 6128555 | |
| Contact: Site 0108 | |
| Local Institution | Recruiting |
| Okayama-shi, Okayama, Japan, 7000914 | |
| Contact: Site 0120 | |
| Local Institution | Recruiting |
| Hirakata-shi, Osaka, Japan, 5731191 | |
| Contact: Site 0104 | |
| Local Institution | Recruiting |
| Suita-shi, Osaka, Japan, 5650871 | |
| Contact: Site 0112 | |
| Local Institution | Recruiting |
| Hidaka-shi, Saitama, Japan, 3501298 | |
| Contact: Site 0121 | |
| Local Institution | Recruiting |
| Bunkyo-ku, Tokyo, Japan, 1138655 | |
| Contact: Site 0114 | |
| Local Institution | Recruiting |
| Chuo-ku, Tokyo, Japan, 1040045 | |
| Contact: Site 0111 | |
| Local Institution | Recruiting |
| Mitaka-shi, Tokyo, Japan, 181-8611 | |
| Contact: Site 0107 | |
| Local Institution | Recruiting |
| Shinjuku-ku, Tokyo, Japan, 1628666 | |
| Contact: Site 0115 | |
| Local Institution | Recruiting |
| Yamagata-shi, Yamagata, Japan, 9909585 | |
| Contact: Site 0117 | |
| Local Institution | Recruiting |
| Kyoto, Japan, 6068507 | |
| Contact: Site 0109 | |
| Netherlands | |
| NKI AVL | Recruiting |
| Amsterdam, Netherlands, 1066 CX | |
| Contact: Dieta Brandsma, Site 0075 +31205122570 | |
| Universitair Medisch Centrum Groningen | Recruiting |
| Groningen, Netherlands, 9713 AP | |
| Contact: Annemiek Walenkamp, Site 0074 +31503616161 | |
| Erasmus Mc | Recruiting |
| Rotterdam, Netherlands, 3015 CE | |
| Contact: Martin Van Den Bent, Site 0073 +31107041415 | |
| Universitair Medisch Centrum Utrecht | Recruiting |
| Utrecht, Netherlands, 3584 CX | |
| Contact: Filip De Vos, Site 0072 +31887556263 | |
| Norway | |
| Local Institution | Recruiting |
| Oslo, Norway, 0424 | |
| Contact: Site 0083 | |
| Poland | |
| Uniwersyteckie Centrum Kliniczne Klinika Onkologii I Radiote | Recruiting |
| Gdansk, Poland, 80-952 | |
| Contact: Renata Zaucha, Site 0086 +48583492257 | |
| Russian Federation | |
| Local Institution | Recruiting |
| Moscow, Russian Federation, 105229 | |
| Contact: Site 0095 | |
| Local Institution | Not yet recruiting |
| Moscow, Russian Federation, 115478 | |
| Contact: Site 0097 | |
| Local Institution | Recruiting |
| Moscow, Russian Federation, 125047 | |
| Contact: Site 0096 | |
| Spain | |
| Local Institution | Recruiting |
| Badalona-barcelona, Spain, 08916 | |
| Contact: Site 0126 | |
| Local Institution | Recruiting |
| Barcelona, Spain, 08035 | |
| Contact: Site 0078 | |
| Local Institution | Recruiting |
| Barcelona, Spain, 08036 | |
| Contact: Site 0125 | |
| Local Institution | Recruiting |
| Madrid, Spain, 28009 | |
| Contact: Site 0077 | |
| Local Institution | Recruiting |
| Madrid, Spain, 28041 | |
| Contact: Site 0076 | |
| Local Institution | Recruiting |
| Santiago Compostela, Spain, 15706 | |
| Contact: Site 0080 | |
| Local Institution | Recruiting |
| Valencia, Spain, 46014 | |
| Contact: Site 0079 | |
| Sweden | |
| Local Institution | Recruiting |
| Lund, Sweden, 221 85 | |
| Contact: Site 0081 | |
| Local Institution | Recruiting |
| Stockholm, Sweden, 171 76 | |
| Contact: Site 0082 | |
| Switzerland | |
| University Hospital Geneva | Recruiting |
| Geneve, Switzerland, 1211 | |
| Contact: Pierre-Yves Dietrich, Site 0065 +41223729861 | |
| Centre hospitalier universitaire Vaudois (CHUV) | Recruiting |
| Lausanne, Switzerland, 1011 | |
| Contact: Andreas Hottinger, Site 0064 | |
| UniversitaetsSpital Zurich | Recruiting |
| Zuerich, Switzerland, 8091 | |
| Contact: Patrick Roth, Site 0063 | |
| United Kingdom | |
| University College Hospital | Recruiting |
| London, Greater London, United Kingdom, NW1 2PG | |
| Contact: Paul Mulholland, Site 0067 +444473809358 | |
| Christie Hospital Nhs Found. Trust | Recruiting |
| Manchester, Greater Manchester, United Kingdom, M20 4BX | |
| Contact: Catherine Mcbain, Site 0066 +441614463000 | |
| Royal Marsden Hospital | Recruiting |
| Sutton, Surrey, United Kingdom, SM2 5PT | |
| Contact: Frank Saran, Site 0119 | |
| Beaston West of Scotland Cancer Centre | Recruiting |
| Glasgow, United Kingdom, G12 0YN | |
| Contact: Stefan Nowicki, Site 0068 +441413017000 | |
Sponsors and Collaborators
Bristol-Myers Squibb
Ono Pharmaceutical Co. Ltd
Investigators
| Study Director: | Bristol-Myers Squibb | Bristol-Myers Squibb |
More Information
Additional Information:
| Responsible Party: | Bristol-Myers Squibb |
| ClinicalTrials.gov Identifier: | NCT02667587 History of Changes |
| Other Study ID Numbers: |
CA209-548 2015-004722-34 ( EudraCT Number ) |
| Study First Received: | January 26, 2016 |
| Last Updated: | July 19, 2017 |
| Studies a U.S. FDA-regulated Drug Product: | Yes | |
| Studies a U.S. FDA-regulated Device Product: | No | |
Additional relevant MeSH terms:
|
Glioblastoma Nivolumab Brain Neoplasms Astrocytoma Glioma Neoplasms, Neuroepithelial Neuroectodermal Tumors Neoplasms, Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms, Glandular and Epithelial Neoplasms, Nerve Tissue Central Nervous System Neoplasms Nervous System Neoplasms |
Neoplasms by Site Brain Diseases Central Nervous System Diseases Nervous System Diseases Temozolomide Dacarbazine Antibodies, Monoclonal Antineoplastic Agents, Alkylating Alkylating Agents Molecular Mechanisms of Pharmacological Action Antineoplastic Agents Immunologic Factors Physiological Effects of Drugs |
ClinicalTrials.gov processed this record on August 23, 2017